SECSONAR

$ATRA

Atara Biotherapeutics, Inc.

NASDAQ

10% Owner bought $4.7M

Up 7% since last report

82% below 52-week high

Insider cost basis

Insiders bought — stock holding above

+12.4%vs buy

Insider buy $9.35Now $10.51

Find before everyone else

SEC filings, insider trades & earnings for ATRA — in one place.